.@BharatBiotech's COVAXIN has been granted approval for emergency use in children from 12 to 18 years of age.
As per the company, the vaccine is formulated in a manner that the same dosage can be administered to adults & children. pic.twitter.com/pCla8eJtoV— Prasar Bharati News Services à€Șà„.à€Źà„.à€à€š.à€à€ž. (@PBNS_India) December 26, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


